Proteinases, cell cycle regulation, and apoptosis during mammary gland involution (minireview)

Molecular Reproduction and Development

Volumn 56, Issue 4, 2000, Pages 534-540

  Wiesen, Jane ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Development; Involution; Mammary gland; Proteinases

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL TISSUE; APOPTOSIS; BREAST CANCER; CELL CYCLE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; INVOLUTION; MAMMARY GLAND; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT SURVEY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL CYCLE; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; MAMMARY GLANDS, ANIMAL; METALLOENDOPEPTIDASES; MICE;

ANIMALIA; MUS MUSCULUS;

EID: 0033934659     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2795(200008)56:4<534::AID-MRD12>3.0.CO;2-O     Document Type: Short Survey

References (53)

1. Alexander CM, Howard EW, Sympson CJ, Bissell MJ, Werb Z. 1996. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135:1669-1677.
2. Alexander CM, Mudgett JS, Hansell EJ, Berger J, Werb Z. 1999. Matrix metalloproteinase function during mammary gland involution. In: Hawkes S, Edwards, D, Khokha R, editors. TIMPs, proceedings of the Banff conference, September 1996 (in press).
3. Ashkenas J, Damsky CH, Bissell MJ, Werb Z. 1994. Integrins, signaling and the remodeling of extracellular matrix. In: Cheresh D, Mecham R, editors. Integrins. Molecular and biological responses to the extracellular matrix. New York: Academic Press, p 79-109.
4. Assoian RK. 1997. Anchorage-dependent cell cycle progression. J Cell Biol 136:1-4.
5. Bartkova J, Lukas J, Müller H, Lützhoft D, Strauss M, Bartek J. 1994. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361.
6. Basbaum CB, Werb Z. 1996. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8:731-738.
7. Bortner DM, Rosenberg MP. 1995. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Diff 6:1579-1589.
8. Bortner DM, Rosenberg MP. 1997. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17:453-459.
9. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
10. Boudreau N, Werb Z, Bissell MJ. 1996. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci USA 93:3509-3513.
11. Capuco AV, Akers RM, Smith JJ. 1997. Mammary growth in Holstein cows during the dry period: quantification of nucleic acids and histology. J Dairy Sci 80:477-87.
12. Coussens LM, Werb Z. 1996. Matrix metalloproteinase expression and neoplasia. Chemistry and Biology 3:895-904.
13. Dickson SR, Warburton MJ. 1992. Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland. J Histochem Cytochem 40:697-703.
14. End P, Panayoutou G, Entwhistle A, Waterfield MD, Chiquet M. 1992. Tenascin: a modulator of cell growth. Eur J Biochem 209: 1041-1051.
15. Evan GI, Wylie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
16. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9:2364-2372.
17. Faraldo MM, Deugnier MA, Lukashev M, Thiery JP, Glukhova MA. 1998. Perturbation of b1-integrin function alters the development of murine mammary gland. EMBO J 17:2139-2147.
18. Fata JE, Leco KJ, Moorehead, RA, Martin DC, Khokha R. 1999. Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211-238-254.
19. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H. 1995. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6:255-263.
20. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT. 1995. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136:1898-1906.
21. Han EK, Begemann M, Sgambato A, Soh JW, Doki Y, Xing WQ, Liu W, Weinstein IB. 1996. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 7:699-710.
22. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91:6875-6879.
23. Hunter T, Pines J. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
24. Jager R, Herzer U, Schenkel J, Weiher H. 1997. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15:1787-1795.
25. Jones PL, Boudreau N, Myers CA, Erickson HP, Bissell MJ. 1995. Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments. J Cell Sci 108:519-527.
26. Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendling C, Lemeur M, Basset P, Rio MC. 1992. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 119:997-1002.
27. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype of mammary epithelial cells. J Cell Biol 139:1861-1872.
28. Lochter A, Sternlicht, M, Werb Z, Bissell MJ. 1998. The significance of matrix metalloproteinases during early stages of tumor progression. Ann NY Acad Sci 857:180-193.
29. Lochter A, Navre M, Werb Z, Bissell MJ. 1999. a1 and a2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 10:271-282
30. Lukashev ME, Werb Z. 1998. ECM signaling: orchestrating cell behavior and misbehavior. Trends Cell Biol 8:437-441.
31. Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K, Werb Z. 1995. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 122:181-193.
32. Ma ZQ, Chua SS, DeMayo FJ, Tsai SY. 1999. Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B. Oncogene 18:4564-4576.
33. Meredith Jr. JE, Fazeli B, Schwartz MA. 1993. The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953-961.
34. Murray A, Hunt T. 1993. The cell cycle. New York: Oxford University Press.
35. Said TK, Medina D. 1995. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis 16:823-830.
36. Said TK, Conneely OM, Medina D, O'Malley BW, Lydon JP. 1997. Progestrone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology 138:3933-3939.
37. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
38. Sicinski P, Weinberg RA. 1997. A specific role for cyclin D1 in mammary gland development. J Mamm Gland Biol Neoplasia 2:335-342.
39. Sherr CJ. 1994. G1 phase progression: cycling on cue. Cell 79: 551-555.
40. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH. 1994. Premature p34cdc2 activation required for apoptosis. Science 263:1143-1145.
41. St. John MAR, et al. 1999. Mice deficient of Last 1 develop soft-tissue sarcomas, ovarian tumors and pituitary dysfunction. Nat Genet 21:182-186.
42. Strange R, Li F, Saurer S, Burkhardt A, Friis RR. 1992. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development 115:49-58.
43. Streuli CH, Gilmore AP. 1999. Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J Mamm Gland Biol and Neoplasia 4:183-191.
44. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125:681-693.
45. Sympson CJ, Bissell MJ, Werb Z. 1995. Mammary gland tumor formation in transgenic animals overexpressing stromelysin-1. Semin Cancer Biol 6:159-163.
46. Talhouk RS, Chin JR, Unemori EN, Werb Z, Bissell MJ. 1991. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 112:439-449.
47. Talhouk RS, Bissell MJ, Werb Z. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118:1271-1282.
48. Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ. 1998. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 153:457-467.
49. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
50. Werb Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
51. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271:17119-17123.
52. Witty JP, Wright JH, Matrisian LM. 1995. Matrix metalloproteinases are expressed during ductal and aveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled aveolar development. Mol Biol Cell 6:1287-1303.
53. Yao Y, Slosberg ED, Wang L, Hibshoosb H., Zhang YJ, Xing WQ, Santella RM, Weinstein IB. 1999. Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice. Oncogene 18:5159-5166.